The market appears to be significantly mispricing Clorox relative to its DCF value, which towers above the recent pricing. With a Forward P/E of 12.62 and an Earnings Yield of 6.76%, the stock is positioned as a potential value play, suggesting the market may be underestimating its future earnings potential. However, the Altman Z-score of 2.62 indicates moderate financial distress, hinting at some underlying risks. The negative Price/Book ratio is a red flag, but the robust ROIC of 32.76% suggests strong capital efficiency, which could mitigate some concerns.
⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.